rs74399089

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_017827.4(SARS2):​c.*99T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00317 in 1,438,862 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 28 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 33 hom. )

Consequence

SARS2
NM_017827.4 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.16

Publications

2 publications found
Variant links:
Genes affected
SARS2 (HGNC:17697): (seryl-tRNA synthetase 2, mitochondrial) This gene encodes the mitochondrial seryl-tRNA synthethase precursor, a member of the class II tRNA synthetase family. The mature enzyme catalyzes the ligation of Serine to tRNA(Ser) and participates in the biosynthesis of selenocysteinyl-tRNA(sec) in mitochondria. The enzyme contains an N-terminal tRNA binding domain and a core catalytic domain. It functions in a homodimeric form, which is stabilized by tRNA binding. This gene is regulated by a bidirectional promoter that also controls the expression of mitochondrial ribosomal protein S12. Both genes are within the critical interval for the autosomal dominant deafness locus DFNA4 and might be linked to this disease. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Mar 2009]
SARS2 Gene-Disease associations (from GenCC):
  • hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia, Orphanet
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-38915507-A-C is Benign according to our data. Variant chr19-38915507-A-C is described in ClinVar as Likely_benign. ClinVar VariationId is 893233.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0112 (1702/152268) while in subpopulation AFR AF = 0.0356 (1480/41546). AF 95% confidence interval is 0.0341. There are 28 homozygotes in GnomAd4. There are 826 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 28 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017827.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SARS2
NM_017827.4
MANE Select
c.*99T>G
3_prime_UTR
Exon 16 of 16NP_060297.1Q9NP81-1
SARS2
NM_001145901.2
c.*99T>G
3_prime_UTR
Exon 17 of 17NP_001139373.1Q9NP81-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SARS2
ENST00000221431.11
TSL:1 MANE Select
c.*99T>G
3_prime_UTR
Exon 16 of 16ENSP00000221431.6Q9NP81-1
ENSG00000269547
ENST00000599996.1
TSL:2
c.*99T>G
3_prime_UTR
Exon 20 of 20ENSP00000472465.1M0R2C6
SARS2
ENST00000897494.1
c.*99T>G
3_prime_UTR
Exon 16 of 16ENSP00000567553.1

Frequencies

GnomAD3 genomes
AF:
0.0112
AC:
1699
AN:
152150
Hom.:
28
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0357
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00543
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00140
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00415
AC:
875
AN:
210770
AF XY:
0.00324
show subpopulations
Gnomad AFR exome
AF:
0.0404
Gnomad AMR exome
AF:
0.00278
Gnomad ASJ exome
AF:
0.00469
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000914
Gnomad NFE exome
AF:
0.00133
Gnomad OTH exome
AF:
0.00270
GnomAD4 exome
AF:
0.00223
AC:
2866
AN:
1286594
Hom.:
33
Cov.:
19
AF XY:
0.00209
AC XY:
1345
AN XY:
642844
show subpopulations
African (AFR)
AF:
0.0376
AC:
1126
AN:
29908
American (AMR)
AF:
0.00303
AC:
121
AN:
39986
Ashkenazi Jewish (ASJ)
AF:
0.00407
AC:
93
AN:
22846
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38658
South Asian (SAS)
AF:
0.000847
AC:
67
AN:
79100
European-Finnish (FIN)
AF:
0.0000515
AC:
2
AN:
38866
Middle Eastern (MID)
AF:
0.0110
AC:
41
AN:
3722
European-Non Finnish (NFE)
AF:
0.00124
AC:
1215
AN:
979242
Other (OTH)
AF:
0.00370
AC:
201
AN:
54266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
140
281
421
562
702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0112
AC:
1702
AN:
152268
Hom.:
28
Cov.:
32
AF XY:
0.0111
AC XY:
826
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0356
AC:
1480
AN:
41546
American (AMR)
AF:
0.00542
AC:
83
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00140
AC:
95
AN:
68010
Other (OTH)
AF:
0.0118
AC:
25
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
89
178
267
356
445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00628
Hom.:
1
Bravo
AF:
0.0122
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.6
DANN
Benign
0.42
PhyloP100
1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74399089; hg19: chr19-39406147; API